ASPECTS OF ARTICULATORY FUNCTION--MOTOR SPEECH DISORDERS
构音功能方面——运动言语障碍
基本信息
- 批准号:6104424
- 负责人:
- 金额:$ 17.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 1999-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The two broad objectives of the current proposal are (a) to understand the
potential relationship between speech breathing and articulation in
persons with motor speech disorders, and (b) to develop a statistical
model of articulatory variability in persons with motor speech disorders,
and to use this model to explain the basis of speech motor control
deficits in this population. More specifically, the aims of the proposed
studies are (a) to understand how modifications in the starting lung
volume for speech affect acoustical and perceptual measures of
articulatory behavior, (b)to determine if persons with motor speech
disorders are able to learn consistent modification of their starting lung
volumes for speech, and (c) to study the statistical relationships between
spectral and temporal properties of formant transitions produced by
persons with motor speech disorders. The experimental plan to address
these aims includes natural observation of the covariation between lung
volume variables and the acoustical/perceptual measures mentioned above,
single-case design methods to evaluate patients' ability to learn the lung
volume modifications, and a paradigm in which speaking rate is
intentionally varied for the purpose of inducing variability in
articulatory processes. When the specific aims identified above are met,
there should be a much better understanding of the factors contributing to
communication deficits in persons with neurological disease, and hence a
better notion of how best to treat the deficit.
当前建议的两个主要目标是(a)了解
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY WEISMER其他文献
GARY WEISMER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY WEISMER', 18)}}的其他基金
ASPECTS OF ARTICULATORY FUNCTION--MOTOR SPEECH DISORDERS
构音功能方面——运动言语障碍
- 批准号:
6346100 - 财政年份:2000
- 资助金额:
$ 17.49万 - 项目类别:
ASPECTS OF ARTICULATORY FUNCTION--MOTOR SPEECH DISORDERS
构音功能方面——运动言语障碍
- 批准号:
6218953 - 财政年份:1999
- 资助金额:
$ 17.49万 - 项目类别:
ASPECTS OF ARTICULATORY FUNCTION--MOTOR SPEECH DISORDERS
构音功能方面——运动言语障碍
- 批准号:
6270166 - 财政年份:1998
- 资助金额:
$ 17.49万 - 项目类别:
ASPECTS OF ARTICULATORY FUNCTION--MOTOR SPEECH DISORDERS
构音功能方面——运动言语障碍
- 批准号:
6238221 - 财政年份:1997
- 资助金额:
$ 17.49万 - 项目类别:
ASPECTS OF ARTICULATORY FUNCTION--MOTOR SPEECH DISORDERS
构音功能方面——运动言语障碍
- 批准号:
5209953 - 财政年份:
- 资助金额:
$ 17.49万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 17.49万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 17.49万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 17.49万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 17.49万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 17.49万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 17.49万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 17.49万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 17.49万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 17.49万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 17.49万 - 项目类别:
Fellowship














{{item.name}}会员




